• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    8/7/23 1:28:18 PM ET
    $AAOI
    $ACGN
    $ADTN
    $AGRI
    Semiconductors
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AAOI alert in real time by email

    Gainers

    • Vistagen Therapeutics, Inc. (NASDAQ:VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol met the primary and secondary endpoints.
    • Save Foods, Inc. (NASDAQ:SVFD) gained 140.6% to $1.54 on abnormally-high volume.
    • Poseida Therapeutics, Inc. (NASDAQ:PSTX) jumped 53% to $2.49. Astellas and Poseida Therapeutics announced strategic investment to support Poseida's commitment to redefining cancer cell therapy.
    • Missfresh Limited (NASDAQ:MF) shares climbed 46.5% to $2.90 on continued upward momentum after the company last week announced entry of share purchase agreements for financing and business acquisition. Also, the company today announced it entered into a share transfer agreement with Freshking Limited.
    • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) shares jumped 44% to $0.1875 after gaining around 7% on Friday.
    • Nektar Therapeutics (NASDAQ:NKTR) gained 41.7% to $0.7549 after the company announced promising new and corrected rezpegaldesleukin efficacy data which were previously reported in 2022 and incorrectly calculated by former collaborator Eli Lilly & Company.
    • Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) jumped 31.6% to $10.30 after the company reported better-than-expected second-quarter financial results.
    • Sequans Communications S.A. (NYSE:SQNS) gained 31% to $2.79 after Renesas Electronics announced it will acquire the company.
    • Oxbridge Acquisition Corp. (NASDAQ:OXAC) rose 29.9% to $14.30. Oxbridge said on August 6, it entered into an agreement with Meteora Capital Partners, Meteora Select Trading Opportunities Master, LP and Meteora Strategic Capital for OTC equity prepaid forward transactions.
    • Blue Star Foods Corp. (NASDAQ:BSFC) jumped 29.5% to $1.1399. Blue Star Foods recently regained compliance with NASDAQ minimum bid price requirement.
    • Sovos Brands, Inc. (NASDAQ:SOVO) rose 25.2% to $22.56 after Campbell Soup announced it would acquire the company for $23 per share in cash.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) gained 20% to $0.30.
    • Veritiv Corporation (NYSE:VRTV) climbed 19.3% to $168.50 after the company announced it will be acquired by CD&R.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) gained 18.7% to $0.2967 after falling 28% on Friday.
    • Mallinckrodt plc (NYSE:MNK) rose 18.7% to $1.6258.
    • Palatin Technologies, Inc. (NYSE:PTN) gained 16.7% to $2.30 as the company announced partnership to make Vyleesi available to patients on UpScriptHealth's telehealth platform.
    • Graham Corporation (NYSE:GHM) jumped 15.7% to $16.15 following better-than-expected quarterly results.
    • Applied Optoelectronics, Inc. (NASDAQ:AAOI) climbed 15.1% to $12.69. Applied Optoelectronics recently reported better-than-expected second-quarter adjusted EPS results.
    • Holley Inc. (NYSE:HLLY) climbed 13.2% to $6.93. Telsey Advisory Group upgraded Holley from Market Perform to Outperform and raised the price target from $3 to $7.5.
    • Integra Resources Corp. (NYSE:ITRG) gained 13.1% to $1.0299.
    • United Homes Group, Inc. (NASDAQ:UHG) gained 12.1% to $11.21.
    • EchoStar Corporation (NASDAQ:SATS) climbed 10.9% to $21.49. Raymond James upgraded EchoStar from Outperform to Strong Buy and announced a $28 price target.
    • Rubicon Technologies, Inc. (NYSE:RBT) shares climbed 10.7% to $1.1290. Rubicon Technologies is expected to release its second quarter 2023 financial results on Aug. 8, 2023.
    • Moxian (BVI) Inc (NASDAQ:MOXC) gained 10.7% to $1.45.
    • Genie Energy Ltd. (NYSE:GNE) climbed 7.6% to $14.71 following second-quarter results.

    Losers

    • Sage Therapeutics, Inc. (NASDAQ:SAGE) shares tumbled 49.2% to $18.33 after the company announced the FDA issued a Complete Response Letter for the New Drug Application for zuranolone in the treatment of adults with major depressive disorder.
    • Tivic Health Systems, Inc. (NASDAQ:TIVC) dipped 38.2% to $0.0443 after the company priced $1.4 million public offering of 33.17 million shares at $0.041 per share.
    • Yellow Corporation (NASDAQ:YELL) shares declined 34.4% to $2.33 after the company said it filed voluntary Chapter 11 petitions.
    • Quantum-Si incorporated (NASDAQ:QSI) fell 33.9% to $2.23 after the company reported worse-than-expected second-quarter sales results.
    • Aceragen, Inc. (NASDAQ:ACGN) fell 33% to $0.50. Aceragen, intends to voluntarily terminate the listing of its common stock on the Nasdaq Capital Market.
    • Tempo Automation Holdings, Inc. (NASDAQ:TMPO) declined 23.2% to $0.2886 after jumping around 50% on Friday.
    • Trinity Biotech plc (NASDAQ:TRIB) fell 22.2% to $0.7399. Trinity Biotech said that it has received 510(k) clearance from the FDA for the premier resolution system.
    • ADTRAN Holdings, Inc. (NASDAQ:ADTN) fell 21.5% to $7.11 after the company reported a year-over-year decrease in second-quarter EPS results and worse-than-expected sales results.
    • DIRTT Environmental Solutions Ltd. (NASDAQ:DRTT) declined 20.8% to $0.4195.
    • WaveDancer, Inc. (NASDAQ:WAVD) fell 19% to $0.3376.
    • Hyzon Motors Inc. (NASDAQ:HYZN) dipped 18.3% to $1.38.
    • Mesoblast Limited (NASDAQ:MESO) fell 17.7% to $1.35. Maxim Group downgraded Mesoblast from Buy to Hold.
    • HUTCHMED (China) Limited (NYSE:HCM) fell 17.2% to $13.63.
    • Ideanomics, Inc. (NASDAQ:IDEX) fell 17% to $0.0746 following quarterly results.
    • Markforged Holding Corporation (NYSE:MKFG) dipped 15.5% to $1.64.
    • Gogo Inc. (NASDAQ:GOGO) fell 15.4% to $13.01 after the company reported mixed second-quarter results and cut its FY23 and long-term growth targets.
    • Nikola Corporation (NASDAQ:NKLA) fell 15.3% to $2.11. On Friday, Nikola reported second-quarter revenue of $15.36 million, which missed estimates of $15.43 million.
    • Curis, Inc. (NASDAQ:CRIS) tumbled 15.3% to $0.5950.
    • Hanryu Holdings, Inc. (NASDAQ:HRYU) fell 15.3% to $6.00. Hanryu recently announced pricing of initial public offering at $10 per share for total of $8.8 million.
    • Aurora Acquisition Corp. (NASDAQ:AURC) fell 14.9% to $38.48.
    • Electriq Power Holdings, Inc. (NASDAQ:ELIQ) declined 13.6% to $3.82.
    • Rigetti Computing, Inc. (NASDAQ:RGTI) declined 13.1% to $2.38.
    • Krystal Biotech, Inc. (NASDAQ:KRYS) tumbled 11.6% to $109.76 after the company reported worse-than-expected second-quarter EPS results.
    • fuboTV Inc. (NYSE:FUBO) fell 11.1% to $2.81.
    • ImmunoGen, Inc. (NASDAQ:IMGN) declined 10.2% to $15.31.
    • Aspen Aerogels, Inc. (NYSE:ASPN) fell 10.2% to $7.04.
    • Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) tumbled 9.3% to $22.23 after Wedbush maintained a Neutral rating on the stock and lowered its price target from $32 to $29..
    • IMAC Holdings, Inc. (NASDAQ:BACK) shares fell 9.1% to $0.1050.
    • Upstart Holdings, Inc. (NASDAQ:UPST) fell 8.7% to $55.42.
    • Sientra, Inc. (NASDAQ:SIEN) fell 8.4% to $3.06. Sientra is expected to release financial results for the second quarter of 2023 on Aug. 10, 2023.
    • Icahn Enterprises L.P. (NASDAQ:IEP) fell 8.2% to $23.04.
    • Sohu.com Limited (NASDAQ:SOHU) shares declined 8% to $11.46 after reporting weak quarterly earnings.
    • Kosmos Energy Ltd. (NYSE:KOS) shares fell 6.5% to $6.84 after the company reported results for its second quarter.
    • Scilex Holding Company (NASDAQ:SCLX) shares fell 6.4% to $5.00 after dropping 15% on Friday.
    • ContraFect Corporation (NASDAQ:CFRX) fell 6.1% to $1.0420.
    • Cloudflare, Inc. (NYSE:NET) shares fell 4.1% to $66.66. Guggenheim downgraded Cloudflare from Neutral to Sell and announced a $50 price target.

     

    Now Read This: Dow Jumps 250 Points; Tyson Foods Posts Downbeat Results

    Get the next $AAOI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAOI
    $ACGN
    $ADTN
    $AGRI

    CompanyDatePrice TargetRatingAnalyst
    Rigetti Computing Inc.
    $RGTI
    4/20/2026$20.00Market Perform
    Northland Capital
    Cloudflare Inc.
    $NET
    4/15/2026$222.00Neutral → Overweight
    Piper Sandler
    ADTRAN Holdings Inc.
    $ADTN
    4/14/2026$18.00Outperform
    Evercore ISI
    Kosmos Energy Ltd.
    $KOS
    4/9/2026$2.25Neutral → Sell
    Goldman
    FuboTV Inc.
    $FUBO
    4/7/2026$16.00Mkt Perform → Outperform
    Barrington Research
    FuboTV Inc.
    $FUBO
    3/30/2026$13.00Mkt Outperform
    Citizens
    Krystal Biotech Inc.
    $KRYS
    3/27/2026Peer Perform
    Wolfe Research
    FuboTV Inc.
    $FUBO
    3/27/2026$18.00Buy
    B. Riley Securities
    More analyst ratings

    $AAOI
    $ACGN
    $ADTN
    $AGRI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Townsend Charles C bought $1,138,706 worth of shares (250,000 units at $4.55) (SEC Form 4)

    4 - Gogo Inc. (0001537054) (Issuer)

    3/13/26 6:48:31 PM ET
    $GOGO
    Telecommunications Equipment
    Consumer Discretionary

    Director Ogunlesi Adebayo O. bought $6,000,000 worth of shares (3,157,895 units at $1.90), increasing direct ownership by 174% to 4,974,184 units (SEC Form 4)

    4 - Kosmos Energy Ltd. (0001509991) (Issuer)

    3/12/26 4:45:15 PM ET
    $KOS
    Oil & Gas Production
    Energy

    SVP and CFO Shah Nealesh D. bought $299,999 worth of shares (157,894 units at $1.90), increasing direct ownership by 9% to 1,863,061 units (SEC Form 4)

    4 - Kosmos Energy Ltd. (0001509991) (Issuer)

    3/12/26 4:44:08 PM ET
    $KOS
    Oil & Gas Production
    Energy

    $AAOI
    $ACGN
    $ADTN
    $AGRI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 26, 2024 - FDA Roundup: March 26, 2024

    For Immediate Release: March 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA proposed a ban of electrical stimulation devices intended to reduce or stop self-injurious or aggressive behavior, a step rarely taken by the agency. The agency has determined that these devices present an unreasonable and substantial risk of

    3/26/24 3:38:14 PM ET
    $IMGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ELAHERE issued to IMMUNOGEN INC

    Submission status for IMMUNOGEN INC's drug ELAHERE (SUPPL-5) with active ingredient MIRVETUXIMAB SORAVTANSINE-GYNX has changed to 'Approval' on 03/22/2024. Application Category: BLA, Application Number: 761310, Application Classification:

    3/22/24 1:48:21 PM ET
    $IMGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 4, 2023 - La FDA aprueba el primer tratamiento oral para la depresión posparto

    For Immediate Release: August 04, 2023 El día de hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó Zurzuvae (zuranolona), el primer medicamento oral indicado para tratar la depresión posparto (DPP) en mujeres adultas. La DPP es un episodio depresivo grave que generalmente ocurre después del parto, pero también puede comenzar durante las últimas etapas

    8/8/23 9:34:19 AM ET
    $SAGE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ACGN
    $ADTN
    $AGRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Chang Hung-Lun (Fred) covered exercise/tax liability with 5,140 shares, decreasing direct ownership by 2% to 228,478 units (SEC Form 4) (for withholding tax)

    4 - APPLIED OPTOELECTRONICS, INC. (0001158114) (Issuer)

    4/24/26 4:02:16 PM ET
    $AAOI
    Semiconductors
    Technology

    President and CEO Lin Chih-Hsiang (Thompson) covered exercise/tax liability with 16,672 shares, decreasing direct ownership by 0.98% to 1,688,605 units (SEC Form 4) to satisfy withholding obligation

    4 - APPLIED OPTOELECTRONICS, INC. (0001158114) (Issuer)

    4/24/26 4:02:17 PM ET
    $AAOI
    Semiconductors
    Technology

    Officer Kuo David C covered exercise/tax liability with 3,585 shares, decreasing direct ownership by 4% to 79,078 units (SEC Form 4) (tax liability)

    4 - APPLIED OPTOELECTRONICS, INC. (0001158114) (Issuer)

    4/24/26 4:02:14 PM ET
    $AAOI
    Semiconductors
    Technology

    $AAOI
    $ACGN
    $ADTN
    $AGRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Rigetti Computing with a new price target

    Northland Capital initiated coverage of Rigetti Computing with a rating of Market Perform and set a new price target of $20.00

    4/20/26 8:28:07 AM ET
    $RGTI
    EDP Services
    Technology

    Cloudflare upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Cloudflare from Neutral to Overweight and set a new price target of $222.00

    4/15/26 8:04:21 AM ET
    $NET
    Computer Software: Prepackaged Software
    Technology

    Evercore ISI initiated coverage on ADTRAN with a new price target

    Evercore ISI initiated coverage of ADTRAN with a rating of Outperform and set a new price target of $18.00

    4/14/26 8:04:53 AM ET
    $ADTN
    Telecommunications Equipment
    Utilities

    $AAOI
    $ACGN
    $ADTN
    $AGRI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

    SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced the closing of its underwritten public offering of $373.8 million of shares of its common stock. Nektar sold 4,062,500 shares of common stock in the offering, which includes 529,891 shares sold upon exercise in full by the underwriters of their option to purchase additional shares of common stock in the offering. The shares of common stock were sold at a public offering price of $92.00 per share. The gross proceeds to Nektar from the offering were approximately $373.8 million, before deducting underwritin

    4/23/26 4:15:00 PM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model

    Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod™ Toward BARDA Funding and Strategic National Stockpile Procurement While Velocity Bioworks CDMO Builds Independent Revenue BaseSAN ANTONIO, April 23, 2026 /PRNewswire/ -- Tivic Health Systems, Inc. (NASDAQ:TIVC) today announced it is changing its corporate name to Valion Bio, Inc. and its Nasdaq ticker symbol from TIVC to VBIO, effective at market open on Tuesday, April 28, 2026. The CUSIP number for the company's common stock will remain unchanged. The rebrand is not merely cosmetic.

    4/23/26 4:05:00 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    INTEGRA ANNOUNCES FIRST QUARTER PRODUCTION RESULTS FROM THE FLORIDA CANYON MINE AND STRENGTHENED BALANCE SHEET

    TSXV: ITR; NYSE American: ITRG www.integraresources.comVANCOUVER, BC, April 23, 2026 /CNW/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV:ITR) (NYSE:ITRG) is pleased to provide an interim operational update for the first quarter ended March 31, 2026 (the "first quarter 2026" or "Q1 2026") highlighting continued operational momentum, record mining rates, and a strengthened balance sheet. The Company plans to release its first quarter 2026 financial results after market close on Monday May 11, 2026, followed by a conference call hosted by senior management on Tuesday

    4/23/26 4:05:00 PM ET
    $ITRG
    Precious Metals
    Basic Materials

    $AAOI
    $ACGN
    $ADTN
    $AGRI
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Curis Inc.

    SCHEDULE 13G - CURIS INC (0001108205) (Subject)

    4/24/26 7:13:45 PM ET
    $CRIS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEFA14A filed by Nektar Therapeutics

    DEFA14A - NEKTAR THERAPEUTICS (0000906709) (Filer)

    4/24/26 4:16:47 PM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Nektar Therapeutics

    DEF 14A - NEKTAR THERAPEUTICS (0000906709) (Filer)

    4/24/26 4:15:45 PM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ACGN
    $ADTN
    $AGRI
    Financials

    Live finance-specific insights

    View All

    Aspen Aerogels, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call

    NORTHBOROUGH, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE:ASPN) ("Aspen" or the "Company") today announced that Don Young, President & Chief Executive Officer, and Grant Thoele, Chief Financial Officer & Treasurer, expect to discuss the Company's financial results for the first quarter ended March 31, 2026, during a conference call scheduled for Thursday, May 7, 2026, at 8:30 a.m. ET. The Company also expects to release its quarterly financial results before the market opens on Thursday, May 7, 2026. Shareholders and other interested parties may participate in the conference call by dialing +1 (833) 461-5787 (domestic) or +1 (585) 542-9983 (international) and ente

    4/23/26 8:00:00 AM ET
    $ASPN
    RETAIL: Building Materials
    Consumer Discretionary

    Holley Performance Brands to Release First Quarter 2026 Results on May 6, 2026

    NASHVILLE, Tenn., April 22, 2026 (GLOBE NEWSWIRE) -- Holley Performance Brands (NYSE:HLLY), a leader in automotive aftermarket performance solutions, today announced the date for the release of its first quarter 2026 financial results. First Quarter 2026 ResultsHolley will host a conference call and live webcast on Wednesday, May 6, 2026, at 8:30 am (Eastern Time) to discuss the Company's first quarter 2026 financial results. The Company's earnings release and presentation for the first quarter 2026 will be issued before the market opens on Wednesday, May 6, 2026, and will be available on the Investor Relations page of the Company's website at investor.holley.com. Hosting the call will b

    4/22/26 8:35:00 AM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026

    PITTSBURGH, April 21, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS) announced today that it will report its first quarter 2026 financial results on Monday, May 4, 2026, prior to the open of U.S. markets. The Company's management will also host a conference call and webcast at 8:30 am ET on Monday, May 4, 2026, to discuss the financial results and provide a business update. Investors and the general public can access the live webcast at: https://www.webcaster5.com/Webcast/Page/3018/53916. For those unable to listen to the live webcast, a replay will be available for at least 30 days on the Investors section of the Company's website at www.krystalbio.com. A

    4/21/26 8:00:00 AM ET
    $KRYS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAOI
    $ACGN
    $ADTN
    $AGRI
    Leadership Updates

    Live Leadership Updates

    View All

    Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services

    Ms. McDonough previously served as Senior Vice President of Patient Access, Analytics, and Operations at Krystal Biotech (NASDAQ:KRYS), where she helped lead the U.S. launch of VYJUVEK®, supporting its growth from FDA approval in 2023 to $389 million in annual sales in 2025 Ms. McDonough to lead Palvella's Market Access and Patient Services organizations, advancing payer engagement, patient support, specialty distribution, and access strategy for the Company's QTORIN™ programs targeting serious, rare skin diseases and vascular malformations WAYNE, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or "the Company") (Nasdaq: PVLA), a clinical-stage biopharmaceut

    3/23/26 7:30:00 AM ET
    $KRYS
    $PVLA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Campbell's Appoints Joshua Levine Chief Investor Relations Officer

    Rebecca Gardy Announces Retirement The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Joshua Levine as Chief Investor Relations Officer, effective March 18, 2026. Levine will report to Chief Financial Officer Todd Cunfer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260313648265/en/Joshua Levine Levine will lead the company's Investor Relations function, overseeing engagement with the investment community and supporting transparent, consistent communication with shareholders. He succeeds Rebecca Gardy, who announced her retirement from the company after six years of leadership in investor rel

    3/13/26 12:25:00 PM ET
    $CPB
    $SMPL
    $SOVO
    Packaged Foods
    Consumer Staples

    INTEGRA RESOURCES ANNOUNCES APPOINTMENT OF CHANTAL LAVOIE TO BOARD OF DIRECTORS

    TSXV: ITR; NYSE American: ITRGwww.integraresources.comVANCOUVER, BC, March 12, 2026 /CNW/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV:ITR) (NYSE:ITRG) is pleased to announce the appointment of Chantal Lavoie, P.Eng., ICD.D, to the Company's Board of Directors. Mr. Lavoie is a mining engineer and seasoned executive with more than 40 years of experience in mine development, operations, capital project execution and corporate governance across gold, base metals, diamonds and iron ore. Most recently, Mr. Lavoie served as Chief Operating Officer of Rio Tinto Iron Ore

    3/12/26 4:05:00 PM ET
    $ITRG
    Precious Metals
    Basic Materials

    $AAOI
    $ACGN
    $ADTN
    $AGRI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by United Homes Group Inc

    SC 13G - United Homes Group, Inc. (0001830188) (Subject)

    12/17/24 5:44:48 PM ET
    $UHG
    Homebuilding
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by United Homes Group Inc

    SC 13D/A - United Homes Group, Inc. (0001830188) (Subject)

    12/13/24 6:24:20 PM ET
    $UHG
    Homebuilding
    Consumer Discretionary